CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...